Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Miletta, Maria Consolata ^a   Petkovic, Vibor ^a   Eblé, Andrée ^a   Ammann, Roland A ^b   Flück, Christa E ^a   Mullis, Primus E ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 41; G PROTEIN COUPLED RECEPTOR 43; GROWTH HORMONE RELEASING FACTOR RECEPTOR; UNCLASSIFIED DRUG; CALCIUM; GPR30 PROTEIN, RAT; GPR43 PROTEIN, RAT; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE SYNTHESIS; HYPOPHYSIS CELL; NONHUMAN; PITUITARY TUMOR CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WILD TYPE; ADENOHYPOPHYSIS; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE SILENCING; GENETICS; METABOLISM;

RATTUS;

ANIMALS; BUTYRIC ACID; CALCIUM; CELL LINE; GENE SILENCING; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; PITUITARY GLAND, ANTERIOR; RATS; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING;

EID: 84907901191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107388     Document Type: Article

References (45)

1. Norrelund H (2005) The metabolic role of growth hormone in humans with particular reference to fasting. Growth Horm IGF Res 15: 95-122.
2. Bratusch-Marrain PR, Smith D, DeFronzo RA (1982) The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55: 973-982.
3. Rizza RA, Mandarino LJ, Gerich JE (1982) Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669.
4. Copeland KC, Nair KS (1994) Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 78: 1040-1047.
5. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, et al. (2013) Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211-214.
6. Cahill GF Jr (2006) Fuel metabolism in starvation. Annu Rev Nutr 26: 1-22.
7. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, et al. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278: 25481-25489.
8. Juul A, Jorgensen JOL (2000) Growth Hormone in Adults: Physiological and Clinical Aspects: Cambridge University Press. 498 p.
9. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. (2003) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278: 11312-11319.
10. Wang A, Gu Z, Heid B, Akers RM, Jiang H (2009) Identification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes. J Dairy Sci 92: 2696-2705.
11. Nilsson NE, Kotarsky K, Owman C, Olde B (2003) Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303: 1047-1052.
12. Ishiwata H, Katoh K, Chen C, Yonezawa T, Sasaki Y, et al. (2005) Suppressing actions of butyrate on growth hormone (GH) secretion induced by GH-releasing hormone in rat anterior pituitary cells. Gen Comp Endocrinol 143: 222-230.
13. Bancroft FC (1973) Intracellular location of newly synthesized growth hormone. Exp Cell Res 79: 275-278.
14. Petkovic V, Godi M, Lochmatter D, Eble A, Fluck CE, et al. (2010) Growth hormone (GH)-releasing hormone increases the expression of the dominantnegative GH isoform in cases of isolated GH deficiency due to GH splice-site mutations. Endocrinology 151: 2650-2658.
15. Besson A, Salemi S, Deladoey J, Vuissoz JM, Eble A, et al. (2005) Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab 90: 2493-2499.
16. Fluck CE, Martens JW, Conte FA, Miller WL (2002) Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay. J Clin Endocrinol Metab 87: 4318-4323.
17. Everitt B, Rabe-Hesketh S (2001) Analyzing Medical Data Using S-PLUS: Springer. 486 p.
18. Yang SK, Wang K, Parkington H, Chen C (2008) Involvement of tetrodotoxinresistant Na+ current and protein kinase C in the action of growth hormone (GH)-releasing hormone on primary cultured somatotropes from GH-green fluorescent protein transgenic mice. Endocrinology 149: 4726-4735.
19. Chang JP, Habibi HR, Yu Y, Moussavi M, Grey CL, et al. (2012) Calcium and other signalling pathways in neuroendocrine regulation of somatotroph functions. Cell Calcium 51: 240-252.
20. Chen C, Xu R, Clarke IJ, Ruan M, Loneragan K, et al. (2000) Diverse intracellular signalling systems used by growth hormone-releasing hormone in regulating voltage-gated Ca2+ or K channels in pituitary somatotropes. Immunol Cell Biol 78: 356-368.
21. Yang SK, Steyn F, Chen C (2012) Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators. Cell Calcium 51: 231-239.
22. Nakamura K, Kamouchi M, Arimura K, Nishimura A, Kuroda J, et al. (2012) Extracellular acidification activates cAMP responsive element binding protein via Na+/H + exchanger isoform 1-mediated Ca(2) (+) oscillation in central nervous system pericytes. Arterioscler Thromb Vasc Biol 32: 2670-2677.
23. Stanley F, Samuels HH (1984) n-Butyrate effects thyroid hormone stimulation of prolactin production and mRNA levels in GH1 cells. J Biol Chem 259: 9768-9775.
24. Yen PM, Tashjian AH Jr (1981) Short chain fatty acids increase prolactin and growth hormone production and alter cell morphology in the GH3 strain of rat pituitary cells. Endocrinology 109: 17-22.
25. Dannies PS, Gautvik KM, Tashjian AH Jr (1976) A possible role of cyclic AMP in mediating the effects of thyrotropin-releasing hormone on prolactin release and on prolactin and growth hormone synthesis in pituitary cells in culture. Endocrinology 98: 1147-1159.
26. Miller AA, Kurschel E, Osieka R, Schmidt CG (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23: 1283-1287.
27. Chen ZX, Breitman TR (1994) Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res 54: 3494-3499.
28. Vescovi PP, Coiro V (2001) Different control of GH secretion by gamma-aminoand gamma-hydroxy-butyric acid in 4-year abstinent alcoholics. Drug Alcohol Depend 61: 217-221.
29. Volpi R, Chiodera P, Caffarra P, Scaglioni A, Malvezzi L, et al. (2000) Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects. Psychoneuroendocrinology 25: 179-185.
30. Quabbe HJ, Trompke M, Luyckx AS (1983) Influence of ketone body infusion on plasma growth hormone and glucagon in man. J Clin Endocrinol Metab 57: 613-618.
31. Yudkoff M, Daikhin Y, Nissim I, Horyn O, Lazarow A, et al. (2005) Response of brain amino acid metabolism to ketosis. Neurochem Int 47: 119-128.
32. Lussier BT, French MB, Moore BC, Kraicer J (1991) Free intracellular Ca2+ concentration ([Ca2+]i) and growth hormone release from purified rat somatotrophs. I. GH-releasing factor-induced Ca2+ influx raises [Ca2+]i. Endocrinology 128: 570-582.
33. Lussier BT, French MB, Moor BC, Kraicer J (1991) Free intracellular Ca2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin. Endocrinology 128: 592-603.
34. Sun S, Li W, Zhang H, Zha L, Xue Y, et al. (2012) Requirement for storeoperated calcium entry in sodium butyrate-induced apoptosis in human colon cancer cells. Biosci Rep 32: 83-90.
35. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, et al. (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4: 1829.
36. Lussier BT, Wood DA, French MB, Moor BC, Kraicer J (1991) Free intracellular Ca2+ concentration ([Ca2+]i) and growth hormone release from purified rat somatotrophs. II. Somatostatin lowers [Ca2+]i by inhibiting Ca2+ influx. Endocrinology 128: 583-591.
37. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, et al. (2004) Shortchain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 101: 1045-1050.
38. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C (1997) Regulation of in vivo growth hormone secretion by leptin. Endocrinology 138: 2203-2206.
39. Tannenbaum GS, Gurd W, Lapointe M (1998) Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 139: 3871-3875.
40. Nohr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, et al. (2013) GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154: 3552-3564.
41. Cummings BP, Bettaieb A, Graham JL, Stanhope KL, Dill R, et al. (2011) Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Proc Natl Acad Sci U S A 108: 14670-14675.
42. Fulop M, Murthy V, Michilli A, Nalamati J, Qian Q, et al. (1999) Serum betahydroxybutyrate measurement in patients with uncontrolled diabetes mellitus. Arch Intern Med 159: 381-384.
43. Gilbert DL, Pyzik PL, Freeman JM (2000) The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 15: 787-790.
44. Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, et al. (1992) Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 74: 757-765.
45. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, et al. (1988) Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81: 968-975.